×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Bharat Parenterals Limited | 752.10 | -78.70 | 722.60 | -10.00 | 662.0 | 24.3 |
| NECTAR LIFESCIENCES LTD. | 4555.55 | 78.4 | 4549.82 | 0.35 | 647 | 38.0 |
| IND-SWIFT LABORATORIES LTD. | 224.77 | 0.06 | 86.65 | 0.00 | 553 | 6.68 |
Bharat Parenterals Limited, with Security Code 541096, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 26.0 | 81.9 | 59.0 | 50.9 | 69.9 | 59.8 | 58.8 | 65.6 | 92.0 | 64.4 |
| Expenses | 24.2 | 72.6 | 55.5 | 44.4 | 58.4 | 53.4 | 52.0 | 61.9 | 77.1 | 58.8 |
| Operating Profit | 1.9 | 9.4 | 3.5 | 6.6 | 11.5 | 6.4 | 6.8 | 3.7 | 15.0 | 5.7 |
| OPM % | 7.42% | 11.42% | 5.91% | 12.93% | 16.44% | 10.75% | 11.53% | 5.7% | 16.28% | 8.78% |
| Other Income | 1.5 | 6.4 | 4.0 | 7.0 | 2.9 | 3.5 | 2.4 | 3.2 | 3.9 | 4.6 |
| Interest | 0.3 | 0.3 | 0.8 | 0.8 | 0.9 | 0.6 | 0.6 | 1.1 | 1.0 | 0.9 |
| Depreciation | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 |
| Profit before tax | 1.7 | 14.0 | 5.2 | 11.3 | 12.0 | 7.7 | 6.9 | 4.3 | 16.3 | 7.6 |
| Tax % | 25.9% | 28.3% | 27.2% | 17.8% | 25.7% | 27.5% | 26.5% | 31.1% | 25.1% | 28% |
| Net Profit | 1.2 | 10.0 | 3.8 | 9.3 | 8.9 | 5.6 | 5.1 | 3.1 | 12.2 | 5.5 |
| EPS in Rs | 2.16 | 17.3 | 6.6 | 16.19 | 15.4 | 9.62 | 8.65 | 5.15 | 20.26 | 7.9 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 81.9 | 59.0 | 51.0 | 69.9 | 59.8 | 59.8 | 67.8 | 92.5 | 71.6 | 72.3 |
| Expenses | 72.7 | 56.4 | 44.8 | 59.5 | 55.5 | 53.2 | 66.8 | 88.0 | 79.3 | 68.6 |
| Operating Profit | 9.2 | 2.6 | 6.2 | 10.5 | 4.3 | 6.6 | 1.0 | 4.5 | -7.7 | 3.6 |
| OPM % | 11.2% | 4.5% | 12.2% | 14.9% | 7.2% | 11.1% | 1.5% | 4.9% | -10.7% | 5% |
| Other Income | 6.4 | 3.5 | 0.3 | 2.1 | 2.6 | 1.3 | 2.6 | 2.5 | 4.2 | 3.0 |
| Interest | 0.3 | 0.8 | 0.8 | 0.9 | 0.6 | 0.6 | 1.1 | 2.8 | 2.9 | 3.3 |
| Depreciation | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.8 | 3.9 | 9.0 | 9.0 | 8.8 |
| Profit before tax | 13.8 | 3.9 | 4.3 | 10.1 | 4.5 | 5.5 | -1.4 | -4.8 | -15.4 | -5.5 |
| Tax % | 28.6% | 36.5% | 47% | 30.5% | 46.5% | 33.5% | -97.8% | -85.5% | -13.9% | -43.1% |
| Net Profit | 9.9 | 2.5 | 2.3 | 7.0 | 2.4 | 3.6 | -2.6 | -8.8 | -17.5 | -7.9 |
| EPS in Rs | 17 | 4 | 4 | 13 | 6 | 6 | 0 | -14 | -27 | -10 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 3% |
| 3 Years: | 8% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 0% |
| 3 Years: | 4% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 38% |
| 3 Years: | 44% |
| 1 Year: | -6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 3% |
| 3 Years: | 8% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -13% |
| 3 Years: | -19% |
| TTM: | -219% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 38% |
| 3 Years: | 44% |
| 1 Year: | -6% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|